SCHEMBL4302011

SCHEMBL4302011

O=C1Nc2cc(OCCCCN3CCN(c4cccc5sccc45)CC3)ccc2[C@@H](O)[C@@H]1O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.65
DRD2 P14416 3/20 0.65
HTR2A P28223 3/20 0.65
ADRB2 P07550 1/20 0.65
ADRB1 P08588 1/20 0.65
ADRA2A P08913 1/20 0.65
ADRA2B P18089 1/20 0.65
ADRA2C P18825 1/20 0.65
DRD1 P21728 1/20 0.65
DRD4 P21917 1/20 0.65
DRD5 P21918 1/20 0.65
SLC6A2 P23975 1/20 0.65
ADRA1D P25100 1/20 0.65
HTR1D P28221 1/20 0.65
HTR1B P28222 1/20 0.65
HTR2C P28335 1/20 0.65
HTR1E P28566 1/20 0.65
SLC6A4 P31645 1/20 0.65
GPR183 P32249 1/20 0.65
HTR7 P34969 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4302769 1.00 HTR1A (0.65) HTR1ADRD2HTR2AADRB2ADRB1
SCHEMBL19888525 0.90 DRD2 (0.67) HTR1ADRD2HTR2AADRB2ADRB1
SCHEMBL25003053 0.88 DRD2 (0.65) HTR1ADRD2HTR2AADRB2ADRB1
SCHEMBL1037444 0.86 DRD2 (0.64) HTR1ADRD2HTR2AADRB2ADRB1
SCHEMBL1037849 0.82 DRD2 (0.75) HTR1ADRD2HTR2AADRB2ADRB1
SCHEMBL29433204 0.82 DRD2 (0.75) HTR1ADRD2HTR2AADRB2ADRB1
Hydrochloric Acid SCHEMBL1035867 0.81 DRD2 (0.74) HTR1ADRD2HTR2AADRB2ADRB1
SCHEMBL1039830 0.81 DRD2 (0.75) HTR1ADRD2HTR2AADRB2ADRB1
SCHEMBL21783311 0.81 HTR1A (0.60) HTR1ADRD2HTR2AADRB2ADRB1
SCHEMBL14772780 0.80 DRD2 (0.63) HTR1ADRD2HTR2AADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2694043-B1 COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER OTSUKA PHARMA CO LTD (JP) 2017-11-01 EP disclosed
WO-2009128537-A1 HETEROCYCLIC COMPOUND 大塚製薬株式会社 (JP) 2009-10-22 WO disclosed